General Information of the Compound
Compound ID
CP0266055
Compound Name
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-(2-methylpropyl)sulfonamido]-3-hydroxy-1-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl}butan-2-yl]carbamate
    Show/Hide
Synonyms
(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL [(1S,2R)-3-[(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO]-2-HYDROXY-1-{4-[(2-METHYL-1,3-THIAZOL-4-YL)METHOXY]BENZYL}PROPYL]CARBAMATE
2fdd
2fde
313682-08-5
AC1NX470
AKOS005145761
BDBM4685
BRECANAVIR
Brecanavir
Brecanavir (USAN)
Brecanavir [USAN:INN]
CHEMBL206031
D03253
DB04887
DTXSID10185296
E367I8C7FI
GSK 640385
GW 0385
GW0385
GW640385
GW64085X
JORVRJNILJXMMG-OLNQLETPSA-N
Proteinase inhibitor 640385
SCHEMBL1533991
UNII-E367I8C7FI
VX 385
VX-385
ZINC3994828
[3H]GW0385
    Show/Hide
Structure
Formula
C33H41N3O10S2
Molecular Weight
703.836
Canonical SMILES
CC(C)CN(C[C@@H](O)[C@H](Cc1ccc(OCc2csc(C)n2)cc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2OCOc2c1
    Show/Hide
InChI
InChI=1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1
    Show/Hide
InChIKey
JORVRJNILJXMMG-OLNQLETPSA-N
CAS
313682-08-5
Physicochemical Property
logP
3.86572
Rotatable Bonds
14
Heavy Atom Count
48
Polar Areas
154.98
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
12
Complexity
48

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5743186
SID: 14989772
ChEMBL ID
CHEMBL206031
DrugBank ID
DB04887
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000036 MDCK-II Canis lupus familiaris (Dog)  1
1
IC50 = 24100 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( BRECANAVIR )
Drug Name BRECANAVIR
Indication
Human immunodeficiency virus infection
Discontinued in Phase 2